Home » Newsletters » BioWorld Science

BioWorld Science

July 13, 2016

View Archived Issues

Servier gains worldwide license to Sorrento's anti-PD-1 antibody

Launch of the Human Cancer Models Initiative

EGCG with cognitive training shows beneficial effects for Down syndrome

Biocad's bispecific MAb shows promise for rheumatoid arthritis in preclinical studies

Amgen initiates first-in-human study of AMG-176 in multiple myeloma

Bayer and X-Chem expand global collaboration for drug discovery in areas of high unmet medical need

BerGenBio patents PKB gamma inhibitors

Forendo Pharma discloses 17beta-HSD1 inhibitors

Seres Therapeutics announces collaboration with Emulate

FDA lifts clinical hold on ROCKET study of JCAR-015

Jazz Pharmaceuticals gives update on acquisiton of Celator Pharmaceuticals

Emory University develops compounds for HBV infections

Pfizer presents prostanoid EP3 receptor antagonists

Seqirus ships seasonal influenza vaccines for the U.S. market

FDA approves Kovanaze nasal spray for dental anesthesia

Roivant Sciences and Plexcera announce formation of Enzyvant Sciences

Murine model of Zika virus disease developed at UTMBHealth

Positive topline results from phase II study of SAGE-547 in severe postpartum depression

Roche Diagnostics and Spanish partners to codevelop NNGS platform

In vitro and in vivo efficacy of novel antimicrobial agent with a dual mechanism of action

EMA committee recommends orphan drug designation for Akari's Coversin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...